AAAAAA
Results:
1-22
|
Results: 22
Authors:
Schmidinger, M
Stager, G
Wenzel, C
Locker, GJ
Budinsky, AC
Brodowicz, T
Kramer, G
Marberger, M
Zielinski, CC
Citation: M. Schmidinger et al., Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: Results of a phase II trial, J IMMUNOTH, 24(3), 2001, pp. 257-262
Authors:
Locker, GJ
Wenzel, C
Schmidinger, M
Gnant, MFX
Marosi, C
Jakesz, R
Zielinski, CC
Steger, GG
Citation: Gj. Locker et al., Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancerpatients, ANTI-CANC D, 12(3), 2001, pp. 209-212
Authors:
Schmidinger, M
Budinsky, AC
Wenzel, C
Locker, GJ
Pluschnig, U
Brodowicz, T
Kubista, E
Maca, S
Zabernigg, A
Ilsinger, P
Seewann, L
Hojas, S
Blach, M
Zielinski, CC
Steger, GG
Citation: M. Schmidinger et al., Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial, CANC CHEMOT, 47(1), 2001, pp. 57-62
Authors:
Traunmuller, F
Thalhammer-Scherrer, R
Locker, GJ
Losert, H
Schmid, R
Staudinger, T
Thalhammer, F
Citation: F. Traunmuller et al., Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients, J ANTIMICRO, 47(2), 2001, pp. 229-231
Authors:
Staudinger, T
Kofler, J
Mullner, M
Locker, GJ
Laczika, K
Knapp, S
Losert, H
Frass, M
Citation: T. Staudinger et al., Comparison of prone positioning and continuous rotation of patients with adult respiratory distress syndrome: Results of a pilot study, CRIT CARE M, 29(1), 2001, pp. 51-56
Authors:
Locker, GJ
Kofler, J
Stoiser, B
Wilfing, A
Wenzel, C
Wogerbauer, M
Steger, GC
Zielinski, CC
Mader, R
Burgmann, H
Citation: Gj. Locker et al., Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2, EUR CYTOKIN, 11(3), 2000, pp. 391-396
Authors:
Stoiser, B
Thalhammer, F
El-Menyawi, I
Wilfing, A
Daxbock, F
Locker, GJ
Burgmann, H
Citation: B. Stoiser et al., Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome, CL DIAG LAB, 7(1), 2000, pp. 119-121
Authors:
Locker, GJ
Stoiser, B
Losert, H
Wenzel, C
Ohler, L
Kabrna, E
Geissler, K
Citation: Gj. Locker et al., Decrease of circulating hematopoietic progenitor cells during interleukin-2 treatment is associated with an increase of vascular cell adhesion molecule-1, a critical molecule for progenitor cell adhesion, LEUK LYMPH, 39(3-4), 2000, pp. 355-364
Authors:
Schmidinger, M
Steger, GG
Budinsky, AC
Wenzel, C
Brodowicz, T
Locker, GJ
Kramer, G
Marberger, M
Zielinski, CC
Citation: M. Schmidinger et al., Vinorelbine and interferon-alpha 2c as second-line therapy in metastatic renal cell carcinoma, ANTI-CANC D, 11(3), 2000, pp. 175-179
Authors:
Locker, GJ
Mader, RM
Steiner, B
Wenzl, E
Zielinski, CC
Steger, GG
Citation: Gj. Locker et al., Benefit of interferon-alpha(2b) in a patient with unresectable hepatoma and chronic infection with hepatitis C virus, EUR J GASTR, 12(2), 2000, pp. 251-253
Authors:
Locker, GJ
Grimm, M
Losert, H
Stoiser, B
Kofler, J
Knapp, S
Wilfing, A
Knoebl, P
Kapiotis, S
Czerny, M
Muhm, M
Hiesmayr, M
Frass, M
Citation: Gj. Locker et al., Prostaglandin E-1 does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting, J CLIN ANES, 12(5), 2000, pp. 363-370
Authors:
Schmidinger, M
Steger, GG
Wenzel, C
Locker, GJ
Brodowicz, T
Budinsky, AC
Wiltschke, C
Kramer, G
Marberger, M
Zielinski, CC
Citation: M. Schmidinger et al., Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial, CANCER IMMU, 49(7), 2000, pp. 395-400
Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
Authors:
Staudinger, T
Stoiser, B
Mullner, M
Locker, GJ
Laczika, K
Knapp, S
Burgmann, H
Wilfing, A
Kofler, J
Thalhammer, F
Frass, M
Citation: T. Staudinger et al., Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit, CRIT CARE M, 28(5), 2000, pp. 1322-1328
Authors:
Schmidinger, M
Budinsky, AC
Wenzel, C
Piribauer, M
Brix, R
Kautzky, M
Oder, W
Locker, GJ
Zielinski, CC
Steger, GG
Citation: M. Schmidinger et al., Glutathione in the prevention of cisplatin induced toxicities - A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer, WIEN KLIN W, 112(14), 2000, pp. 617-623
Authors:
Locker, GJ
Steger, GG
Gnant, MFX
Steiner, B
Simonitsch, I
Krainer, M
Budinsky, A
Brodowicz, T
Spitzauer, S
Jakesz, R
Zielinski, CC
Citation: Gj. Locker et al., Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?, J IMMUNOTH, 22(1), 1999, pp. 85-89
Authors:
Staudinger, T
Frass, M
Rintelen, C
Quehenberger, P
Wagner, O
Stoiser, B
Locker, GJ
Laczika, K
Knapp, S
Watzke, H
Citation: T. Staudinger et al., Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients, INTEN CAR M, 25(10), 1999, pp. 1105-1110
Authors:
Thalhammer, F
Traunmuller, F
El Menyawi, I
Frass, M
Hollenstein, UM
Locker, GJ
Stoiser, B
Staudinger, T
Thalhammer-Scherrer, R
Burgmann, H
Citation: F. Thalhammer et al., Continuous infusion versus intermittent administration of meropenem in critically ill patients, J ANTIMICRO, 43(4), 1999, pp. 523-527
Authors:
Stoiser, B
Vorbeck, F
Kofler, J
Locker, GJ
Burgmann, H
Citation: B. Stoiser et al., Placement of a pulmonary artery catheter via a previously unrecognized persistent left superior vena cava, VASA, 28(1), 1999, pp. 53-54
Authors:
Wenzel, C
Schmidinger, M
Locker, GJ
Taucher, S
Gnant, M
Jakesz, R
Steger, GG
Citation: C. Wenzel et al., Clinical phase II evaluation of the combination therapy with Docetaxel andEpidoxorubicin in the neoadjuvant, cytostatic treatment on patients with primary breast cancer (T1-4, N0-2, M0), WIEN KLIN W, 111(20), 1999, pp. 843-850
Authors:
Locker, GJ
Mader, RM
Rizovski, B
Knapp, S
Domanovits, H
Muellner, M
Hoeller, C
Steger, GG
Sterz, F
Freissmuth, M
Frass, M
Laggner, AN
Citation: Gj. Locker et al., Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: Hemodynamic and pharmacokinetic interactions, J PHARM EXP, 290(1), 1999, pp. 43-50
Authors:
Locker, GJ
Kapiotis, S
Veitl, M
Mader, RM
Stoiser, B
Kofler, J
Sieder, AE
Rainer, H
Steger, GG
Mannhalter, C
Wagner, OF
Citation: Gj. Locker et al., Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders, BR J HAEM, 105(4), 1999, pp. 912-919
Authors:
Kettner, SC
Panzer, OP
Kozek, SA
Seibt, FA
Stoiser, B
Kofler, J
Locker, GJ
Zimpfer, M
Citation: Sc. Kettner et al., Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery, ANESTH ANAL, 89(3), 1999, pp. 580-584
Risultati:
1-22
|